drug

Rating Scales

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
PROCEDURE
Pre-approval / investigational in the US
Developed by AstraZeneca
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
PROCEDURE

Indications

Trials

1
FAST-A Study to Evaluate the Efficacy and Safety of Quetiapin IR in Patients With Acute Psychosis
NCT00486798Phase 3Terminated

KOLs & investigators

2
Birgit Ekholm, MD
Jaan Ruusa, MD,PhD

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
AstraZeneca
company
trial
FAST-A Study to Evaluate the Efficacy and Safety of Quetiapin IR in Patients With Acute Psychosis
PHASE3
trial
indication
Schizophrenia
indication
Bipolar Disorder
indication
Schizophrenia
indication
Psychotic Disorders
indication
KOL
Birgit Ekholm, MD
KOL score —
person
Jaan Ruusa, MD,PhD
KOL score —
person